CCONH
AGN

Crosby Company of New Hampshire’s Allergan plc AGN Stock Holding History

Crosby Company of New Hampshire’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-369,849
Closed -$82.5M – 11
2014
Q2 		$82.5M Buy
+369,849
New +$76.6M 49.6% 1

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Crosby Company of New Hampshire's AGN Position: Q3 2014 in Review

Crosby Company of New Hampshire sold out of Allergan plc (AGN) in Q3 2014, closing a stake of 369,849 shares — an estimated $82.5M sold.

Crosby Company of New Hampshire first reported a position in AGN in Q2 2014 and held it in 1 quarter. The position peaked at $82.5M in Q2 2014. 753 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Crosby Company of New Hampshire reported no remaining Allergan plc position as of Q3 2014 after selling out during the quarter.
  • Crosby Company of New Hampshire sold 369,849 Allergan plc shares in Q3 2014, an estimated $82.5M.
  • Crosby Company of New Hampshire first reported a position in Allergan plc in Q2 2014 and held it in 1 quarter.
  • Crosby Company of New Hampshire's Allergan plc position peaked at $82.5M in Q2 2014.
  • 753 funds tracked by Wall St. Rank held Allergan plc as of Q3 2014.

Based on Crosby Company of New Hampshire's 13F filing for Q3 2014.